Evaluation of Cardiovascular Health Outcomes Among Survivors
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer, Peripheral Vascular Disease |
Therapuetic Areas: | Cardiology / Vascular Diseases, Oncology |
Healthy: | No |
Age Range: | Any |
Updated: | 11/18/2012 |
Start Date: | March 2010 |
End Date: | February 2014 |
Contact: | Melissa Hudson, MD |
Email: | info@stjude.org |
Phone: | 1-866-278-5833 |
This study will test a 2-tiered tailored intervention and evaluation of cardiovascular
health outcomes among survivors designed to inform childhood cancer survivors about their
individual cardiac risk and follow-up recommendations and to provide motivational support
for cardiovascular (CV) screening. This study will test if the addition of telephone
motivational interviewing, tailored to behavioral constructs, is superior to the current
standard of care in increasing survivors' CV screening.
- This study will test the hypothesis that at 1 year post-intervention, a significantly
greater proportion of the advanced-practice nurse (APN) phone counseling group will
have undergone cardiovascular screening, as compared to the standard care group.
Cardiovascular (CV) screening will be defined, based on established CV screening
recommendations, as completion of an imaging evaluation of left ventricular systolic
function (i.e., echocardiogram, multiple uptake gated acquisition scan, or cardiac
magnetic resonance imaging).
- This study will measure changes induced by the intervention in survivors' knowledge,
motivation, fear, beliefs, affect, readiness for medical follow-up, and self-efficacy
and these changes' potential mediating effects on CV screening.
- This study will provide a cost analysis of the ECHOS intervention in terms of the
cost of left ventricular systolic function imaging per additional survivor
screened, an estimate of the cost of standard care per survivor screened, and the
cost of screening and follow-up per survivor screened.
Inclusion Criteria:
1. Childhood Cancer Survivor Study (CCSS) cohort participants
2. Age 25 years or older
3. No CV screening in previous 5 years
4. Received anthracycline chemotherapy and/or irradiation of the chest
5. Previous history of successful independent (non-surrogate) response to CCSS surveys
(reading level for non-medical items is 4th-6th grade Flesch-Kincaid level).
Exclusion Criteria:
1. Being followed at an institution actively recruiting adults to a long-term follow-up
program (ascertained in CCSS follow-up database)
2. Inability or unwillingness of research participant to give written informed consent.
We found this trial at
1
site
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
Click here to add this to my saved trials